INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MJ
Morical Gregory JSVP, GENERAL COUNSEL
CLMTCalumet, Inc. /DE
Grant or award
A—
6,197 sh
Feb 24, 2026Feb 26, 2026
Page 1247 of 1786
← PrevNext →
traded Feb 24, 2026
+2d
SEC Form 4

Evidence

9
DN
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$5,806
12.4K sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
GS
Gannon Michael SChief Revenue Officer
SNOWSnowflake Inc.
Grant or award
A—
3,428 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
CF
Carter FowlerDirector, Co-CEO and President
BSMBlack Stone Minerals, L.P.
Tax withholding
F$4,950
325 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
DA
Discenza Michael AnthonyEVP, Chief Financial Officer
TKRTIMKEN CO
Option exercise
M—
1,825 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
JN
Jain NikunjPrincipal Accounting Officer
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$2,406
5,119 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
PD
Pfeiffer DeborahEVP & Pres, Presort Services
PBIPITNEY BOWES INC /DE/
Option exercise
M—
3,805 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
JN
Jain NikunjPrincipal Accounting Officer
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$315
666 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
FS
Fogarty SiobhanChief Technology Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
MS
Minder ScottChief Financial Officer
MATVMativ Holdings, Inc.
Grant or award
A—
30.6K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$393
832 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
RM
Rakita MelanieVice President & CHRO
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Tax withholding
F$29K
83 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
134.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
NM
Navratil Chris MChief Financial Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
547 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
CB
Cree BrianPresident
VTSVitesse Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$118K
5,282 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Grant or award
A$881
31 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Option exercise
M—
8,765 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
DT
DeWalch TaylorDirector, Co-CEO and President
BSMBlack Stone Minerals, L.P.
Tax withholding
F$7,280
478 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
BJ
Bower Kenneth JDirector
SMBCSOUTHERN MISSOURI BANCORP, INC.
Grant or award
A—
400 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
CM
Curtis Monica MEVP & Chief Legal Officer
METMETLIFE INC
Grant or award
A—
420 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Option exercise
M—
5,890 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

9
DT
DeWalch TaylorDirector, Co-CEO and President
BSMBlack Stone Minerals, L.P.
Grant or award
A—
1,958 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
BC
Bonner ChrisSVP, CFO, and Treasurer
BSMBlack Stone Minerals, L.P.
Grant or award
A—
1,447 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
BL
Beneteau LesleySVP, CHRO
VLTOVeralto Corp
Option exercise
M—
7,004 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
RJ
Rambeau JonPres., Coms. & Spec. Dom.
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Option exercise
M—
3,034 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
10 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
134.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
SB
Saenger BradleyChief Financial Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
RE
Rodgers ElliottDirector
LEVILEVI STRAUSS & CO
Small acquisition
L$4,752
216 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
CJ
Christina JosephDirector, CEO and President
NDLSNOODLES & Co
Tax withholding
F$7,919
1,483 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
FS
Fogarty SiobhanChief Technology Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
644 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

8
BC
Brown ChristianDirector, Chief Executive Officer
CTRICenturi Holdings, Inc.
Tax withholding
F$151K
4,893 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
2,548 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
1,274 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$7,539
183 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
677 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

7
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Grant or award · 10b5-1 plan
A—
30.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
MS
Mehta SamirPres., Space & Mission Sys.
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Option exercise
M—
3,034 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
CE
Cho EstherChief Legal Officer
KROSKeros Therapeutics, Inc.
Grant or award
A—
80.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence